View More Recent Stories

Feb 26, 2025 08:04AM Opus Genetics (IRD) Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs

Feb 18, 2025 07:30AM Opus Genetics (IRD) Announces Updates on OPGx-LCA5 Clinical Program

Dec 19, 2024 08:01AM Opus Genetics (IRD) Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330

Nov 13, 2024 06:52AM H.C. Wainwright Assumes Opus Genetics (IRD) at Buy

Nov 12, 2024 08:04AM Opus Genetics, Inc. (IRD) Misses Q3 EPS by 4c

View More Recent Stories